Yourgene Health Receives HSA approval for IONA Nx NIPT Workflow in Singapore
Manchester, UK - Yourgene Health plc (“Yourgene”, AIM: YGEN), a leading international molecular diagnostics group, announces it has received Health Sciences Authority (HSA) approval for its IONA® Nx NIPT Workflow in Singapore.
New studies - guided imagery is helpful for sleep and specifically for sleep quality
Guided imagery is relaxation technique that is a way of imagining yourself in a place that brings you happiness.
cofinitive nominated for Community Champion award in British Chambers of Commerce ‘Chamber Business Award 2022’
cofinitive is thrilled to announce its been nominated for a British Chambers of Commerce (BCC) ‘Chamber Business Award 2022’ in ‘The Community Champion’ category.
How do you empower your teams? New cohort on Trust Works programme now open for registration
Are you wondering how to provide more autonomy to your teams and empower your workforce? And how this leads to improved results and better staff engagement? Then join Trust Works' Moving Towards Self-Management programme, the next cohort of which starts in November.
Up to £100k of investment available from BRAN with Allia’s new Accelerator Challenge
Allia is looking for impact start-ups across the UK that have innovative solutions for addressing some of the world’s most pressing issues such as cleantech, agetech, social inclusion and homelessness.
New research from Singular Talent reveals 52% of biotech employees want freedom from their boss
Specific research on the world of work in Biotech is hard to find.Moving forward: CleanCube Mobile Cleanrooms embrace the changing landscape
Guardtech’s award-winning portable controlled environments set to offer solutions for range of new applications
Celebrating 20 years – rethinking recruitment since 2002
Pure celebrates 20 years in the business. That’s 20 years of helping clients find people, helping people find jobs, and supporting organisations across the eastern region with their recruitment strategies.
Knowledge from noise - new algorithm turns uncertainty into a positive for industrial R&D and beyond
A recently published paper in the prestigious journal Applied Intelligence introduces a novel method by which machine learning can extract valuable information from uncertainty or noise in input data.
Cresset secures significant growth funding from SEP
Cresset, a drug discovery software scaleup, raises growth capital from SEP to accelerate its product development and international expansion.
Have you ever Googled ‘How to sleep better’?
Those who suffer with insomnia will know all too well that there’s bewildering array of information out there advising us how to improve our sleep, to the extent it’s difficult to know what actually works and where to start! Sleep has become a multimillion-pound global industry, with so many products, gadgets, teas, sprays, lotions, you-name-it, all promising a quick fix to transport us into the…
WaveFX stream team remote webcasting in Sweden
Ahead of a newly commissioned 8-part Scandinavian documentary the WaveFX team have just returned from a 10-day trial filming and live streaming from a self-built raft drifting at 4mph down the Klarälven river. ("The clear river" in Swedish).
Introducing the high capacity microscope slide loader
Prior Scientific is pleased to introduce its newest automated slide loader, the SL160.
Accounting & Finance for Entrepreneurs Workshop
Small businesses and startups are invited to a FREE online workshop that Watermill Accounting is hosting from 14.00 - 15.00 on Wednesday 12th October 2022.
Springboard wins Mixed Crew event at the annual Dragon Boat Festival
Springboard are proud winners of the mixed crew event at the Dragon Boat Festival that was held over the weekend. The race was in aid of the local Addenbrookes Charitable Trust, a much-loved charity in the Cambridge area.
New technology heralds smoother injections
You know that horrid juddering noise that windscreen wipers make sometimes? This is caused by alternate sticking and slipping of rubber on glass. The same phenomenon occurs with the rubber plunger in a glass syringe, albeit with more serious consequences including uncomfortable injections, variability in dosing, and wastage of drug.
The Lee Company Inc. acquires TTP Ventus Limited
WESTBROOK, Connecticut (USA) - The Lee Company is pleased to announce that it has acquired TTP Ventus Limited from TTP Group.
New Certified Climate Change Training
In conjunction with The Carbon Literacy project we are offering individuals from all sectors the opportunity to be certified as Carbon Literate by attending our course on 7 November 2022.
More about prenatal Physical Activity
A supervised prenatal Physical Activity can be started after the 3rd month and after a medical check-up.
Results from EBCam's Employee Benefits and Rewards Survey released
Local employee benefit specialists and financial advisers EBCam Ltd share the results from their first annual employee benefit and reward survey. EBCam launched an employee benefits and rewards survey earlier this year and invited local businesses to take part to aid them in benchmarking their rewards and benefits. Now, having closed the survey last month, EBCam has shared this years’ results…
CIIPM Training - new autumn training courses
CIIPM returns to in-person training for 4 half-day courses in IP&Commercialisation and Freedom to Operate searching
H.E.L Group strengthens leadership team to focus on new product development and enhanced customer support
Alan Lockley joins as Director of Global Services, Edward Quinn as Director of Product Development and Mark Appleton takes new role as Director of Research.
PhoreMost enters multi-project drug target discovery collaboration with Roche
PhoreMost to deploy its SITESEEKER platform to identify novel targets for Roche’s discovery programmes.
Avacta announces AVA6000 receives Orphan Drug Designation from the US Food and Drug Administration
London and Wetherby, UK - Avacta Group plc, a clinical stage oncology drug company and developer of powerful diagnostics based on its innovative Affimer® and pre|CISION™ platforms, announces that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to the company’s lead pre|CISION drug candidate, AVA6000, for treatment of soft tissue sarcoma.